This HNF4α mutations might decrease the expression of SLC2A2 in both liver and kidney, and are responsive to diazoxide therapy, unlike the Fanconi-Bickel syndrome (20, 21). The gene discussed is SLC2A2; the disease is glycogen storage disease due to GLUT2 deficiency.